In today’s session Direxion Daily S&P Biotech Bull 3X Shares (LABU) registered an unusually high (332) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the November, 2016 call, expecting serious LABU increase. With 332 contracts traded and 17434 open interest for the Nov, 16 contract, it seems this is a quite bullish bet. The option with symbol: LABU161118C00045000 closed last at: $1.35 or 71.9% down. Direxion Daily S&P Biotech Bull 3X Shares (NYSEARCA:LABU) has risen 24.82% since April 18, 2016 and is uptrending. It has outperformed by 20.39% the S&P500.
More notable recent Direxion Daily S&P Biotech Bull 3X Shares (NYSEARCA:LABU) news were published by: Marketwatch.com which released: “Direxion Daily S&P Biotech Bull 3X Shares” on March 08, 2014, also Quotes.Wsj.com with their article: “DOW JONES, A NEWS CORP COMPANY” published on May 29, 2015, Etftrends.com published: “Triple-Leveraged Biotech ETFs Could be Coming Soon” on March 20, 2015. More interesting news about Direxion Daily S&P Biotech Bull 3X Shares (NYSEARCA:LABU) were released by: Benzinga.com and their article: “Don’t Get SICK Of Healthcare ETFs And Stocks; Try This Instead” published on November 15, 2016 as well as Investorplace.com‘s news article titled: “Be Careful Before Loving Leveraged Biotech ETFs” with publication date: October 06, 2015.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.